TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.

Iván Márquez-Rodas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.